Xingbai Received Flucarbazone Registration in China
Chinese firm Shijiazhuang Xingbai Bioengineering Ltd, recently received national registration for 96% flucarbazone TC from ICAMA (Institute for the Control of Agrochemicals，MOA), China, valid until November 2019. Xingbai is the first domestic company who obtained this registration. Previously, Arysta North America gained the approval of 95% flucarbazone TC in China. Developed by Bayer, flucarbazone belongs to ALS-inhibitor herbicide. This product can be absorbed through plant root and leave and is systemic.
In 2000, Bayer brought it to US and Canadian market particularly for wild oat and green foxtail control in wheat. In 2003, Bayer divested it to Arysta, with sales improving consistently year on year. In 2008, Arysta introduced this product as Pre-Pare in the USA for burndown pre-planting use on winter and spring wheat. After that, Arysta launched Everest (flucarbazone + fluroxypyr) in Canada for grass and broadleaf control on spring wheat in 2010. Under agreement, Arysta supplied Syngenta with flucarbazone, which the company marketed as Sierra for use on wheat, gaining US approval for the product in 2011. In 2011 Arysta introduced the product in a mixture with fluroxypyr as Raze in India market. The sales performance of flucarbazone in 2012 was $115 million.
|
.jpg){kind=small}